Pérez Figueroa, G.E., Guevara-Salinas , A., Álvarez -Luquín , D. and Adalid Peralta, L. 2024. Dopaminergic agonists and L-DOPA, used to treat Parkinson’s disease, induce dopamine receptor expression on immune cells. Archivos de Neurociencias. 29, S1 (Apr. 2024).